intern seminar 題目 : Kawasaki disease -2 (a) 1. About long-term management of Kawasaki disease with transient coronary artery dilatation (disappearing within the initial 6 to 8 weeks after the onset of illness): (a) No antiplatelet therapy is needed (b) Long-term antiplatelet therapy solely is recommended (c) Long-term antiplatelet therapy with warfarin is recommended (d) Long-term thrombolytic therapy is recommeded (c) 2. About long-term management of Kawasaki disease with persistent giant aneurysms (a) No antiplatelet therapy is needed (b) Long-term antiplatelet therapy solely is recommended (c) Long-term antiplatelet therapy with warfarin is recommended, target INR 2.0:2.5 (d) Long-term thrombolytic therapy is recommeded (d) 3. What is initial treatment of Kawasaki disease (a) Steroid solely (b) Steroid + high dose Aspirin (c) Steroid + lose dose Aspirin (d) IVIG + high dose Aspirin (d) 4. About long-term management of Kawasaki disease with coronary artery obstruction confirmed by angiography (a) Monitoring for risk factors of atherosclerosis is unnecessary (b) No antiplatelet therapy is needed (c) Beta-adrenergic-blocking drugs should be avoided (d) Cardiology evaluation with an echocardiogram and ECG should be obtained at 6-month intervals ※ 編輯: kawasaku 來自: 140.112.128.107 (08/25 10:36)